SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Scott will provide his perspective on the investment outlook for early stage companies on a panel at the Bloom Burton & Co Technology Transfer Conference May 21 in Toronto.
News | 05. 21. 2013
Scott will provide his perspective on the investment outlook for early stage companies on a panel at the Bloom Burton & Co Technology Transfer Conference May 21 in Toronto.
